277 related articles for article (PubMed ID: 35272862)
1. Circulating tumor cells in precision medicine: challenges and opportunities.
Rupp B; Ball H; Wuchu F; Nagrath D; Nagrath S
Trends Pharmacol Sci; 2022 May; 43(5):378-391. PubMed ID: 35272862
[TBL] [Abstract][Full Text] [Related]
2. Circulating tumor cells as biomarkers in head and neck cancer: recent advances and future outlook.
Tinhofer I; Staudte S
Expert Rev Mol Diagn; 2018 Oct; 18(10):897-906. PubMed ID: 30199647
[TBL] [Abstract][Full Text] [Related]
3. Application of liquid biopsy in precision medicine: opportunities and challenges.
Wang J; Chang S; Li G; Sun Y
Front Med; 2017 Dec; 11(4):522-527. PubMed ID: 28744793
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumor cells in breast cancer: applications in personalized medicine.
Lee JS; Magbanua MJM; Park JW
Breast Cancer Res Treat; 2016 Dec; 160(3):411-424. PubMed ID: 27761678
[TBL] [Abstract][Full Text] [Related]
5. Liquid biopsy for ovarian cancer using circulating tumor cells: Recent advances on the path to precision medicine.
Yang J; Cheng S; Zhang N; Jin Y; Wang Y
Biochim Biophys Acta Rev Cancer; 2022 Jan; 1877(1):188660. PubMed ID: 34800546
[TBL] [Abstract][Full Text] [Related]
6. Understanding the organ tropism of metastatic breast cancer through the combination of liquid biopsy tools.
Gerratana L; Davis AA; Polano M; Zhang Q; Shah AN; Lin C; Basile D; Toffoli G; Wehbe F; Puglisi F; Behdad A; Platanias LC; Gradishar WJ; Cristofanilli M
Eur J Cancer; 2021 Jan; 143():147-157. PubMed ID: 33307492
[TBL] [Abstract][Full Text] [Related]
7. The potential of liquid biopsy in the management of cancer patients.
Markou A; Tzanikou E; Lianidou E
Semin Cancer Biol; 2022 Sep; 84():69-79. PubMed ID: 35331850
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic cancer circulating tumor cells: applications for personalized oncology.
DiPardo BJ; Winograd P; Court CM; Tomlinson JS
Expert Rev Mol Diagn; 2018 Sep; 18(9):809-820. PubMed ID: 30099926
[TBL] [Abstract][Full Text] [Related]
9. Development and Application of Liquid Biopsies in Metastatic Prostate Cancer.
Morrison GJ; Goldkorn A
Curr Oncol Rep; 2018 Mar; 20(4):35. PubMed ID: 29572775
[TBL] [Abstract][Full Text] [Related]
10. Tracking cancer progression: from circulating tumor cells to metastasis.
Castro-Giner F; Aceto N
Genome Med; 2020 Mar; 12(1):31. PubMed ID: 32192534
[TBL] [Abstract][Full Text] [Related]
11. Metastatic Melanoma: Liquid Biopsy as a New Precision Medicine Approach.
Ricciardi E; Giordani E; Ziccheddu G; Falcone I; Giacomini P; Fanciulli M; Russillo M; Cerro M; Ciliberto G; Morrone A; Guerrisi A; Valenti F
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835424
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer.
De Luca F; Rotunno G; Salvianti F; Galardi F; Pestrin M; Gabellini S; Simi L; Mancini I; Vannucchi AM; Pazzagli M; Di Leo A; Pinzani P
Oncotarget; 2016 May; 7(18):26107-19. PubMed ID: 27034166
[TBL] [Abstract][Full Text] [Related]
13. Single-cell analysis of CTCs with diagnostic precision: opportunities and challenges for personalized medicine.
Alberter B; Klein CA; Polzer B
Expert Rev Mol Diagn; 2016; 16(1):25-38. PubMed ID: 26567956
[TBL] [Abstract][Full Text] [Related]
14. Promises and Pitfalls of Using Liquid Biopsy for Precision Medicine.
Rossi G; Ignatiadis M
Cancer Res; 2019 Jun; 79(11):2798-2804. PubMed ID: 31109952
[TBL] [Abstract][Full Text] [Related]
15. Genomic Landscape of Liquid Biopsy for Hepatocellular Carcinoma Personalized Medicine.
Moldogazieva NT; Zavadskiy SP; Terentiev AA
Cancer Genomics Proteomics; 2021; 18(3 Suppl):369-383. PubMed ID: 33994362
[TBL] [Abstract][Full Text] [Related]
16. Circulating tumor cell as the functional aspect of liquid biopsy to understand the metastatic cascade in solid cancer.
Cortés-Hernández LE; Eslami-S Z; Alix-Panabières C
Mol Aspects Med; 2020 Apr; 72():100816. PubMed ID: 31377345
[TBL] [Abstract][Full Text] [Related]
17. Cell-Free DNA in the Liquid Biopsy Context: Role and Differences Between ctDNA and CTC Marker in Cancer Management.
Fici P
Methods Mol Biol; 2019; 1909():47-73. PubMed ID: 30580422
[TBL] [Abstract][Full Text] [Related]
18. Liquid Biopsy-Based Biomarkers of Treatment Response and Resistance.
Kilgour E; Rothwell DG; Brady G; Dive C
Cancer Cell; 2020 Apr; 37(4):485-495. PubMed ID: 32289272
[TBL] [Abstract][Full Text] [Related]
19. [Innovations in personalized medicine : Molecular characterization of liquid biopsy-fake or fact?].
Theil G; Fornara P
Urologe A; 2018 Sep; 57(9):1069-1074. PubMed ID: 29971453
[TBL] [Abstract][Full Text] [Related]
20. Liquid biopsy in breast cancer: A comprehensive review.
Alimirzaie S; Bagherzadeh M; Akbari MR
Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]